Skip to main content

Basal Cell Carcinoma News (Page 2)

Related terms: Basal Cell Skin Cancer, Cancer, Basal Cell Carcinoma, Rodent Ulcer, Skin Cancer, Basal Cell, BCC

In Situ, Invasive Melanoma Diagnoses Decreased in 2020

THURSDAY, Sept. 7, 2023 – During 2020, there were decreases seen for in situ and invasive melanoma diagnoses, according to a research letter published online Sept. 6 in JAMA Dermatology. Daniel Y....

FDA Approves Libtayo (cemiplimab-rwlc) as First Immunotherapy Indicated for Patients with Advanced Basal Cell Carcinoma

TARRYTOWN, N.Y. and PARIS, Feb. 9, 2021 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced that the U.S. Food and Drug Administration (FDA) approved the PD-1 ...

FDA Approves Odomzo (sonidegib) for Locally Advanced Basal Cell Carcinoma

July 24, 2015 – The U.S. Food and Drug Administration today approved Odomzo (sonidegib) to treat patients with locally advanced basal cell carcinoma that has recurred following surgery or radiation...

FDA Approves Erivedge for Basal Cell Carcinoma

  SILVER SPRING, Md., Jan. 30, 2012 /PRNewswire-USNewswire/ – Today, Erivedge (vismodegib) was approved by the U.S. Food and Drug Administration to treat adult patients with basal cell carcinoma, ...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Skin Cancer

Related drug support groups

Efudex